Combining our results with the previously reported close relationship among the ETS family, cilia and tumour formation, it is plausible that the modulation of ETS1 oncogenic efficacy is accomplished, at least in part, by primary cilia, which provides new insight into the mechanism for the oncogenic efficacy of ETS TFs, which needs further verification. This evidence concerns the gene ETS1 and neoplasm.